Ligand Pharmaceuticals Inc
XBER:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
XBER:LGDN
|
US |
|
Cineverse Corp
NASDAQ:CNVS
|
US |
|
P
|
Paychex Inc
XBER:PCX
|
US |
|
E
|
Exxaro Resources Ltd
JSE:EXX
|
ZA |
|
A
|
Apple Inc
LSE:0R2V
|
US |
|
J
|
Juniper Networks Inc
F:JNP
|
US |
|
Mitsubishi HC Capital Inc
F:5B4
|
JP |
|
A
|
Adecco Group AG
XBER:ADI1
|
CH |
|
NexPoint Residential Trust Inc
NYSE:NXRT
|
US |
|
G
|
Gildan Activewear Inc
F:VGA
|
CA |
|
M
|
Microchip Technology Inc
XBER:MCP
|
US |
|
S
|
Sumitomo Corp
DUS:SUMA
|
JP |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
F
|
Farmland Partners Inc
SWB:0FA
|
US |
|
K
|
Kulicke and Soffa Industries Inc
F:KU1
|
SG |
|
Bank Central Asia Tbk PT
F:BZG
|
ID |
|
Rheinmetall AG
F:RHMB
|
DE |
|
Grifols SA
MAD:GRF
|
ES |
|
S
|
SBA Communications Corp
SWB:4SB
|
US |
|
M
|
Mitsubishi Chemical Group Corp
DUS:M3C
|
JP |
|
A
|
Allstate Corp
XHAM:ALS
|
US |
|
Pearson PLC
LSE:PSON
|
UK |
|
P
|
Pembina Pipeline Corp
F:P5P
|
CA |
|
N
|
Nov Inc
F:NO8
|
US |
Dividends
Dividend Yield
Ligand Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Ligand Pharmaceuticals Inc
LGDN have decreased by 0%.
Payout Ratio
Ligand Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for LGDN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LGDN Price
Ligand Pharmaceuticals Inc
| Average Annual Return | 11.48% |
| Standard Deviation of Annual Returns | 49.32% |
| Max Drawdown | -68% |
| Market Capitalization | 4.1B EUR |
| Shares Outstanding | 17 960 000 |
| Percentage of Shares Shorted |
N/A
|
LGDN Return Decomposition
Main factors of price return
Stock Splits
LGDN's latest stock split occurred on Nov 19, 2010
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
The adjusted shares began trading on Nov 19, 2010. This was the only stock split in LGDN's history.
